Related Experiment Video
Updated: Jun 23, 2025

Intracerebroventricular Delivery of Gut-Derived Microbial Metabolites in Freely Moving Mice
Published on: June 2, 2022
Bile acids and the gut microbiome are involved in the hyperthermia mediated by 3,4-methylenedioxymethamphetamine
Srishti Rana1, Jeremy R Canfield2, Christopher S Ward1
1Department of Biological Sciences, Bowling Green State University, Bowling Green, OH, 43403, USA.
Abstract:
Hyperthermia induced by phenethylamines, such as 3,4-methylenedioxymethamphetamine (MDMA), can lead to life-threatening complications and death. Activation of the sympathetic nervous system and subsequent release of norepinephrine and activation of uncoupling proteins have been demonstrated to be the key mediators of phenethylamine-induced hyperthermia (PIH). Recently, the gut microbiome was shown to also play a contributing role in PIH. Here, the hypothesis that bile acids (BAs) produced by the gut microbiome are essential to PIH was tested. Changes in the serum concentrations of unconjugated primary BAs cholic acid (CA) and chenodeoxycholic acid (CDCA) and secondary BA deoxycholic acid (DCA) were measured following MDMA (20 mg/kg, sc) treatment in antibiotic treated and control rats. MDMA-induced a significant hyperthermic response and reduced the serum concentrations of three BAs 60 min post-treatment. Pretreatment with antibiotics (vancomycin, bacitracin and neomycin) in the drinking water for five days resulted in the depletion of BAs and a hypothermic response to MDMA. Gut bacterial communities in the antibiotic-treated group were distinct from the MDMA or saline treatment groups, with decreased microbiome diversity and alteration in taxa. Metagenomic functions inferred using the bioinformatic tool PICRUSt2 on 16S rRNA gene sequences indicated that bacterial genes associated to BA metabolism are less abundant in the antibiotic-MDMA treated group. Overall, these findings suggest that gut bacterial produced BAs might play an important role in MDMA-induced hyperthermia.
Insights
The gut microbiome
Area of Science:
- Pharmacology
- Microbiology
- Toxicology
Background:
- Phenethylamines, like MDMA, can cause dangerous hyperthermia.
- Sympathetic nervous system activation and uncoupling proteins are known mediators.
- The gut microbiome's role in this hyperthermia is a recent area of investigation.
Purpose of the Study:
- To test the hypothesis that gut microbiome-produced bile acids (BAs) are essential for phenethylamine-induced hyperthermia (PIH).
Main Methods:
- Rats were treated with MDMA (3,4-methylenedioxymethamphetamine) after antibiotic pretreatment to deplete BAs.
- Serum BA concentrations and body temperature were measured.
- Gut microbiome composition and function were analyzed using 16S rRNA sequencing and bioinformatics.
Main Results:
- MDMA induced hyperthermia and reduced serum BA levels.
- Antibiotic pretreatment depleted BAs, reduced microbiome diversity, and resulted in hypothermia following MDMA.
- Bacterial genes related to BA metabolism were less abundant in antibiotic-treated rats.
Conclusions:
- Gut bacterial-derived bile acids may play a critical role in MDMA-induced hyperthermia.
- Modulating the gut microbiome could be a potential strategy to mitigate PIH.
Related Concept Videos
Homeostatic Imbalances in Body Temperature
Increased Body Temperature
Phase II Reactions: Methylation Reactions
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
Thermoregulation
Hepatic Drug Excretion: Enterohepatic Cycling
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Hepatic Drug Excretion: Influencing Factors

